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reveals molecular mechanisms that uncouple UHRF2
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ABSTRACT

INTRODUCTION

UHRF1 is a histone- and DNA-binding E3 ubiquitin ligase that functions with DNMT1 to maintain mammalian DNA methylation. UHRF1 facilitates
DNMT1 recruitment to replicating chromatin through
a coordinated mechanism involving histone and
DNA recognition and histone ubiquitination. UHRF2
shares structural homology with UHRF1, but surprisingly lacks functional redundancy to facilitate
DNA methylation maintenance. Molecular mechanisms uncoupling UHRF2 from DNA methylation
maintenance are poorly defined. Through comprehensive and comparative biochemical analysis of recombinant human UHRF1 and UHRF2 reader and
writer activities, we reveal conserved modes of histone PTM recognition but divergent DNA binding
properties. While UHRF1 and UHRF2 diverge in their
affinities toward hemi-methylated DNA, we surprisingly show that both hemi-methylated and hemihydroxymethylated DNA oligonucleotides stimulate
UHRF2 ubiquitin ligase activity toward histone H3
peptide substrates. This is the first example of an
E3 ligase allosterically regulated by DNA hydroxymethylation. However, UHRF2 is not a productive
histone E3 ligase toward purified mononucleosomes,
suggesting UHRF2 has an intra-domain architecture
distinct from UHRF1 that is conformationally constrained when bound to chromatin. Collectively, our
studies reveal that uncoupling of UHRF2 from the
DNA methylation maintenance program is linked to
differences in the molecular readout of chromatin
signatures that connect UHRF1 to ubiquitination of
histone H3.

A major challenge of modern biology has been to determine
how DNA-templated processes like transcription, replication and repair are temporally and spatially regulated in the
context of chromatin. Histone post-translational modifications (PTMs) and DNA methylation have emerged as key
regulators of chromatin accessibility, interaction, and signaling. Breakthroughs in our understanding of chromatin
regulatory mechanisms have been made through the characterization of protein machineries that write, erase, and read
these epigenetic marks. The faithful mitotic inheritance of
DNA methylation patterns is essential for mammalian development and is well studied for its key roles in the stable transcriptional silencing of genes and transposable elements, genomic imprinting, and X-chromosome inactivation (1). DNA methylation patterns are established by de
novo methyltransferases during early embryonic development and are maintained through somatic cell divisions by
the maintenance methyltransferase DNMT1 (DNA methyltransferase 1), which has increased catalytic activity toward
hemi-methylated DNA (He5mC) (2–4). The E3 ubiquitin
ligase UHRF1 (ubiquitin-like, containing PHD and RING
finger domains 1) is now appreciated as a key regulator
of DNMT1-mediated DNA methylation maintenance. Genetic and biochemical studies revealed that UHRF1 plays
a central role in DNMT1-directed DNA methylation maintenance during DNA replication (5,6). Deletion of Uhrf1
(or Np95) in mice is embryonic lethal, and stem cells derived from Uhrf1−/− embryos (and also from human cells
depleted of UHRF1) show a dramatic loss in DNA methylation, impaired maintenance of higher-order chromatin
structure, and spurious transcription of otherwise silenced
repetitive DNA elements (6–9).
The DNA methylation maintenance function of UHRF1
is dependent on its ability to bind chromatin, where it facilitates ubiquitination of histone H3 at lysines 18 and 23
(H3K18ub and H3K23ub, respectively), a proposed dock-
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contribute to a divergence in the writing of nucleosomal histone ubiquitination.
MATERIALS AND METHODS
Cell culture and plasmids
HeLa were originally purchased from ATCC and maintained in Dulbecco’s Modified Eagle Medium (Life Technologies) supplemented with 10% FBS (Sigma) and 1%
penicillin/streptomycin solution (Thermo), at 37◦ C with
5% CO2 . For bacterial expression, full length open reading frames of UHRF1 (1–793) and UHRF2 (1–802) were
cloned by Gibson Assembly (NEB) into a modified pQE
vector in frame with an N-terminal 6X histidine–maltose
binding protein-tobacco etch virus cleavage site (6XHisMBP-TEV). TTD-PHD (UHRF1: 125–364; UHRF2: 119–
392) domains were cloned into pGEX-4T1 as N-terminal
GST fusions. The expression construct for UBA1 was a gift
from Dr Cynthia Wolberger (Addgene plasmid #34965).
UBCH5A was a gift from Dr Rachel Klevit. The expression construct for TEV enzyme was a gift from Dr Jiyan
Ma. The pSEB-N3F (N-terminal 3X-FLAG) used in chromatin association assays was a gift from Tong-Chuan He.
UHRF2 ORFs were cloned into pSEB-N3F with HindIII
and MluI restriction sites.
Chromatin association assays
HeLa cells were transfected with XtremeGene HP (Roche)
at a 3:1 ratio with plasmid DNA in 60 mm dishes. After 48
h, cells were harvested by scraping into cold 1× PBS pH 7.6,
pelleted at 1000 g for 5 min, and resuspended in 120 l cold
CSK buffer (10 mM PIPES pH 7.0, 300 mM sucrose, 100
mM NaCl, 3 mM MgCl2 , 0.1% Triton X-100, protease inhibitors (Roche; 1 tablet per 20 ml)). Cells were kept on ice
for 20 min. Total protein was quantified by Bradford Assay
(BioRad), and 10% was combined with an equivalent volume of cold endonuclease-supplemented CSK (Pierce, 250
units/5 ml). Note that the concentration of the total fraction is now 0.5×. Remaining cell lysates were centrifuged at
1300 g for 5 min at 4◦ C. The supernatant (soluble fraction)
was collected. The chromatin pellet was washed 1× in CSK
buffer, and pelleted 1300 g for 5 min at 4◦ C. The supernatant
was discarded and the chromatin pellet was solubilized in
cold endonuclease-supplemented CSK buffer. Five microgram of total protein and volume equivalents of chromatin
and soluble fractions were loaded for western blot analysis.
Recombinant protein production
Bacterial expression constructs were transformed into
BL21(DE3) Escherichia coli and grown at 37◦ C in LB
Lennox (Cassion) media in baffled flasks at 160 rpm. When
cells reached an OD600 = 0.8–1.0, the temperature was lowered to 16◦ C, IPTG was added (0.5 mM), and cultures were
incubated with shaking for 16 h. Bacteria were harvested
by centrifugation and washed 1× with cold PBS pH 7.6.
Pellets were either frozen at –80◦ C or resuspended in lysis
buffer (His-tag: 50 mM Tris–HCl pH 8.0, 500 mM NaCl,
20 mM imidazole, 1 mM PMSF and 1 mM DTT; GST-tag:
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ing site for DNMT1 (10–13). UHRF1 has three domains
that directly bind chromatin. The SRA (SET and RINGassociated) domain of UHRF1 is a DNA-binding domain
that recognizes 5-methylcytosine (5mC) in the context of
hemi-methylated double-stranded CpG dinucleotides (14–
16). UHRF1 also binds the unmodified N-terminus of histone H3 through a plant homeodomain (PHD) finger
(17,18) and di- and tri-methylated lysine 9 on histone H3
(H3K9me2/me3) through an aromatic cage in the first subdomain of its tandem Tudor (19,20). Our studies showed
that multivalent recognition of histone H3 by the UHRF1
TTD-PHD is required for its DNA methylation maintenance function in human cancer cells (21). We and others also defined a positive allosteric relationship between
the histone- and DNA-binding activities of UHRF1 and
showed that SRA binding to He5mC allosterically activates
its ubiquitin ligase activity toward histone substrates (22–
24).
The UHRF protein family has at least two bona fide
members (25). UHRF2 is an E3 ubiquitin ligase that is
also capable of SUMOylating proteins (26,27). However,
there are few known substrates of UHRF2 s ubiquitin and
SUMO ligase activities (28). UHRF2 is highly homologous
to UHRF1 in sequence and structure (Supplementary Figure S1), but it does not appear to be functionally redundant in the maintenance of DNA methylation (22,29,30).
The inability of UHRF2 to functionally compensate for
UHRF1 is further demonstrated by the reduction of 5mC in
Uhrf1-null mESCs, despite similar levels of Uhrf1 and Uhrf2
transcripts (DBTMEE, (31)). Recent studies reported that
UHRF2 is a reader of 5hmC (32,33) and is required to
maintain 5hmC levels in the brains of mice (34,35).
A mechanistic explanation for why UHRF2 is uncoupled
from DNA methylation maintenance is lacking. Here, we
compare and contrast the biochemical activities of UHRF1
and UHRF2 with modified histone peptides, DNA oligonucleotides, and purified mononucleosomes. We reveal similarities and differences in the reader and writer functions of these proteins. While UHRF1, but not UHRF2,
has enhanced affinity for He5mC over unmodified DNA
(UnDNA), He5mC stimulates the enzymatic activity of
both UHRF proteins toward H3 peptide substrates. Surprisingly, the enzymatic activity of UHRF2, and to a lesser
extent UHRF1, is stimulated by He5hmC, despite its inability to discriminate this mark from UnDNA or symmetrically modified (Sy5mC or Sy5hmC) DNA. Notably, we
show that histone peptides, as substrates of UHRF1 and
UHRF2 ubiquitin ligase activity, do not reveal differences
that are apparent when using purified mononucleosomes as
substrates. Our studies are consistent with a report showing that UHRF2 is unable to recruit DNMT1 to replicating chromatin (29), a finding we now propose is a result
of its inability to ubiquitinate chromatinized histone substrates. Collectively, our studies reveal that the uncoupling
of UHRF2 from the DNA methylation maintenance program is linked, at least in part, to differences in the molecular readout of chromatin signatures that connect UHRF1 to
ubiquitination of histone H3. We suggest that differences in
UHRF protein interactions with chromatin, presumably resulting from distinct intramolecular domain organization,
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Fluorescence polarization
For histone binding analysis, H3(1–20) peptides functionalized with N- or C-terminal 5-carboxyfluorescein (FAM)
were synthesized by the High Throughput Peptide Synthesis and Array (HTPSA) Core Facility at UNC Chapel Hill.
H3(1–20) peptides without FAM were used when monitoring the allosteric relationship between histone and DNA
binding. For DNA binding analysis, complementary 12-bp
DNA oligonucleotides with the following sequences [FAM5 -CCATGXGCTGAC-3 and 5 -GTCAGYGCATGG-3
(UnDNA: X and Y are cytosine, He5mC: X is 5mC and Y
is cytosine, Sy5mC: X and Y are 5mC, He5hmC: X is 5hmC
and Y is cytosine, Sy5hmC: X and Y are 5hmC)] were resuspending in STE buffer (10 mM Tris–HCl pH 8.0, 100 mM
NaCl, 1 mM EDTA). Equimolar amounts of sense and antisense oligos were combined and boiled in a water bath for
10 min, followed by slow cooling to room temperature to
anneal. Oligo hybridization was checked by 20% PAGE followed by fluorescent imaging of the FAM-labeled duplex
as well as by SYBR Gold (Thermo) staining of ssDNA.
Oligos containing 5mC were synthesized by Eurofins Genomics, and those containing 5hmC were synthesized by the
Keck Oligonucleotide Synthesis Facility (Yale University).
For histone and DNA binding, proteins were characterized
as either MBP- or GST-fusions. Proteins were titrated with
10 nM FAM-ligand in FP assay buffer (25 mM HEPES
pH 7.5, 100 mM NaCl, 0.05% NP-40). For allosteric DNA
binding analysis (Figure 3B), FP assay buffer included 150
mM NaCl. Assays in 25 l volumes were performed at room

temperature using black 384-well plates (Costar). Polarization (P) was measured on a Synergy Neo fluorescence microplate reader (Biotek). Fluorescence intensities were converted to anisotropy (A) with the equation A = 2P/3-P. Dissociation constants (Kd ) were calculated by nonlinear regression analysis of anisotropy curves using a one-site binding model with Hill slope in GraphPad Prism. Error is reported as ± standard error of the mean (S.E.M.) from technical triplicate measurements. Presented data is representative of at least two biological replicates (new protein preps
and DNA probes). We note some variability in measured
binding constants across biological replicates. To control for
this, each comparative DNA binding assay (UnDNA versus HeDNA versus SyDNA, and UHRF1 versus UHRF2)
was performed in the same 384-well plate at the same time.
The variability that we present is due to both biological and
technical error, and compounded by difficulties in fitting
Kd for low affinity interactions. A complete list of binding
constants and associated errors from FP measurements are
listed in Supplementary Table S3.
Ubiquitination assays
In vitro ubiquitination reactions were performed in 20 l
volumes for 20 min (unless otherwise indicated) at room
temperature in ubiquitin assay buffer (50 mM HEPES pH
7.5, 66 mM NaCl, 8 mM ATP, 2.5 mM MgCl2 , 2.5 mM
DTT). For all reactions (except Supplementary Figure S4),
6xHis-MBP tags were cleaved from UHRF1 and UHRF2.
Reactions contained 1.5 M E3, 50 nM E1 UBA1, 667 nM
E2 UBCH5A, 5 M TAMRA-ubiquitin (BioVision), and
13 M H3(1–32) K9me2 (C-terminal biotin), and 6.25 M
12-bp duplex DNA oligo. The DNA oligos used in ubiquitination reactions have the same sequence and modifications as those used for fluorescence polarization, but were
synthesized without FAM label. For in vitro ubiquitination
of HeLa mononucleosomes, reactions were run in ubiquitin assay buffer containing 1.5 M E3, 50 nM E1 UBA1,
667 nM E2 UBCH5A, 5 M TAMRA-ubiquitin, and 0.5
M HeLa mononucleosomes (Epicypher). In the comparative time course ubiquitination reaction of peptide (1 M)
and nucleosome (0.5 M), moles of H3 were equal, and
He5mC (6.25 M) was only added to the peptide reactions.
Reactions were quenched by the addition of 5× SDS loading buffer (250 mM Tris–HCl pH 6.8, 50% glycerol, 10%
SDS, 6% beta-mercaptoethanol, 0.25% bromophenol blue)
to a final concentration of 1×. Fresh beta-mercaptoethanol
was added to the loading buffer to reduce E1-ub and E2-ub
conjugates Ubiquitinated species were directly imaged in gel
by Cy3 fluorescence (TAMRA-ubiquitin) on an Azure c400
imaging platform.
Nucleosome pulldowns
For in vitro nucleosome pulldowns, 5 l of streptavidincoated magnetic bead slurry (Pierce) per pulldown was equilibrated in pulldown buffer (25 mM HEPES pH 7.5, 100
mM NaCl, 0.5% BSA, 0.1% NP-40). Beads were incubated
with 50 pmoles of H3K9me3-containing recombinant biotinylated nucleosomes (Epicypher) for 30 min at room
temperature. Conjugated beads were washed twice for 5 min

Downloaded from https://academic.oup.com/nar/article-abstract/46/9/4405/4913573 by University of the Pacific user on 20 November 2018

1× D-PBS, 1 mM PMSF and 1 mM DTT). Lysis was performed on ice by addition of lysozyme (30 min), followed
by five rounds of sonication (20 s of sonication, followed
by 2 min on ice) at 40% amplitude with a micro-tip (Branson Digital 450). Lysates were cleared by centrifugation at
38 000 g for 30 min at 4◦ C. Purification was performed by
batch technique as follows. Cleared lysates were mixed for
1 h at 4◦ C with His60 Superflow Resin (Clontech) or glutathione agarose (Pierce), 5 ml equilibrated in Buffer A (Histag: 50 mM Tris–HCl pH 8.0, 500 mM NaCl, 20 mM imidazole; GST-tag: 1× D-PBS). Resin and bound protein were
washed three times with 20 bed volumes of Buffer A, followed by elution in five bed volumes of Buffer B (His-tag:
25 mM HEPES pH 7.5, 100 mM NaCl, 250 mM imidazole; GST-tag: 1× D-PBS, 10 mM L-glutathione (Sigma)).
Protein was either concentrated (Amicon Ultra 15, 30K
MWCO) and injected onto a HiLoad 26/600 Superdex 200
(GE Healthcare) size-exclusion column equilibrated in SEC
buffer (25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT)
or dialyzed into TEV cleavage buffer (His-tag: 50 mM Tris–
HCl pH 8.0, 1 mM DTT, 0.5 mM EDTA) with recombinant TEV protease (500 nM). Recombinant TEV protease
was purified as described (36). Cleavage of the 6X His–MBP
tag was performed overnight at 4◦ C, and the cleaved protein
was isolated by size-exclusion chromatography. Fractions
were checked for purity by SDS-PAGE and were pooled and
concentrated. MBP- and GST-fusions were concentrated to
>80 M, and frozen at –80◦ C with 20% glycerol. Cleaved
proteins were concentrated to >20 M and snap frozen in
small aliquots without glycerol.
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Histone peptide microarrays
Histone peptide synthesis (UNC HTPSA), fabrication of
the microarray, and protein domain hybridization was performed as previously described (37,38). Briefly, arrays were
blocked for 30 min in cold array hybridization buffer (1×
PBS pH 7.6, 0.1% Tween-20, 5% BSA (OmniPur, Fraction
V)) and GST-tagged proteins (1 M) were hybridized to
the microarray in a humidified chamber overnight at 4◦ C.
Bound protein was labeled with ␣-GST primary and AlexaFluor 647-conjugated secondary antibodies (Supplementary Table S1). Microarrays were fluorescently imaged at 20
m resolution on an Innoscan 1100AL microarray scanner (Innopsys). Image processing and data analysis was
performed as previously described with ArrayNinja (39).
For heat map construction, arrays were normalized to each
other by IgG control spots and the brightest peptide was
set equal to 1 (blue). Peptides were then ranked for UHRF1
TTD-PHD from high to low. Each unique peptide feature
(see Supplementary Table S2 for a full list of peptide features spotted on the array) was spotted in triplicate two
times per subarray, and values presented are the average of
measured signals for these individual peptide spots.
Western blotting
After separation by SDS-PAGE, proteins were transferred
to 0.45 m PVDF membrane (Amersham Hybond P) using
a semi-dry transfer apparatus (Hoefer) for 1.5 h at a constant current of 1 mA/cm2 . Membranes were blocked for 1
h at room temperature in blotting buffer (1× PBS pH 7.6,
0.1% Tween-20, 5% BSA). Primary antibodies (Supplementary Table S1) were hybridized overnight at 4◦ C with gentle
agitation in blotting buffer. Membranes were then washed
three times for 5 min in blotting buffer. HRP-conjugated
secondary antibodies (GE Life Sciences) were hybridized
at room temperature for 1 h in blotting buffer. Membranes
were again washed three times for 5 min in blotting buffer
and reacted with ECL Prime (GE Life Sciences). Blots were
exposed to film and developed on a Kodak system.
RESULTS
UHRF1 and UHRF2 TTD-PHD have conserved reader activities towards the N-terminus of histone H3
The inability of endogenous UHRF2 to maintain cellular
DNA methylation, in the absence of UHRF1, led us to hypothesize that differences in chromatin recognition and/or
enzymatic activity contribute to a lack of UHRF2 functional redundancy with UHRF1. To test this hypothesis,
we systematically compared and contrasted the reader and
enzymatic activities of these proteins, including appreciated

mechanisms of UHRF1 intramolecular crosstalk through
multivalent histone and DNA engagement (22,23), as well
as allosteric control of enzymatic activity by He5mC (24).
We first used histone peptide microarrays to query, in a
high-throughput and parallel manner, the reader activities
of the linked TTD-PHD domains of UHRF1 and UHRF2.
The arrays displayed a synthetic library of over 250 unique
modified histone peptides harboring single and combinations of PTMs (Supplementary Table S2), derived largely
from mass spectrometry datasets (40–43). UHRF1 and
UHRF2 TTD-PHD preferentially bound H3 peptides (Figure 1A and B), and both preferentially bound to H3K9me2and H3K9me3-containing peptides (Figure 1B and C).
Consistent with the known interaction of the UHRF1 PHD
with the free N-terminus of H3 (17,18), PTMs on the first six
residues of the H3 N-terminus perturbed UHRF1 histone
binding on the arrays (Supplementary Figure S2). UHRF2
binding to arrays appeared less affected by N-terminal H3
PTMs.
To further query the individual TTD and PHD contributions to histone binding, we next generated predicted lossof-function mutations in the UHRF2 TTD-PHD based on
structural alignments with UHRF1 (Supplementary Figure S3, TTD*: tandem Tudor mutant, PHD*: plant homeodomain finger mutant). Both the TTD*-PHD and TTDPHD* of UHRF1 and UHRF2 were again profiled by histone peptide microarray. Consistent with the TTD as the
methyl-lysine reading unit (19,20), the TTD*-PHD from
both UHRF1 and UHRF2 exhibited reduced reader activity toward H3K9 methylation (Figure 1C–E). Although
subtle, UHRF2 TTD-PHD* maintained some binding to
peptides containing H3K9me2/me3 while UHRF1 TTDPHD* did not (Figure 1C and F–G), suggesting the interaction between UHRF2 and H3 may be less dependent
on its PHD finger than UHRF1. Consistently, UHRF2
was more tolerant of asymmetric di-methylation of H3R2
(H3R2me2a) than UHRF1 (Figure 1C and Supplementary
Figure S2B), a PTM known to inhibit H3 binding through
the UHRF1 PHD (44,45).
We next used fluorescence polarization (FP) binding assays to quantitatively measure interactions between UHRF1 and UHRF2 TTD-PHD and H3 peptides.
UHRF1 TTD-PHD had a ∼4-fold increase in affinity for
H3(1–20) K9me3 over the unmodified tail (H3(1–20) K9un),
while UHRF2 had a ∼7-fold increase in affinity for
H3(1–20) K9me3 over H3(1–20) K9un (Figure 2A). As predicted from peptide array experiments, UHRF1 and
UHRF2 TTD mutations demonstrated a lack of selectivity for H3K9me3 (Figure 2B). Consistent with UHRF1 and
UHRF2 TTD-PHD binding the H3 tail in a multivalent
manner (20,21), PHD mutations, or the addition of an Nterminal FAM to H3 tail peptides, greatly disrupted measured interactions of UHRF1 and UHRF2 (Figure 2). FP
binding assays with full-length UHRF1 and UHRF2 verified that the H3K9me3 reader properties of the isolated
TTD-PHD were conserved in full-length protein (Supplementary Figure S5A). Collectively, these results demonstrate that UHRF1 and UHRF2 have conserved histone
binding properties through multivalent TTD-PHD engagement of H3K9me2/me3 peptides.
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in pulldown buffer. The indicated GST- or MBP-fusions
(500 pmol) were incubated with conjugated beads overnight
at 4◦ C. Beads were then washed three times for 5 min in
pulldown buffer. Beads were boiled in 100 l of 1× SDS
loading buffer (50 mM Tris–HCl pH 6.8, 10% glycerol,
2% SDS, 1.2% beta-mercaptoethanol, 0.05% bromophenol
blue), and 10 l was loaded onto gels for western blot. Input
lanes were loaded with 1% of the unbound protein fraction.
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Figure 1. Functional requirements of histone PTM recognition are conserved between the UHRF1 and UHRF2 TTD-PHD. Scatter plots of normalized
signal intensities from two subarrays hybridized with the indicated wild-type (A, B) and mutant (D–G) TTD-PHD domains of UHRF1 or UHRF2. Each
spot represents average signal from a unique peptide feature (see Supplementary Table S2 for a full list of peptide features spotted on the array) and is
color-coded by histone (A, D, F) or methylation state of H3(1–20) K9 (B, E, G) as described in the key. Peptides are spotted in triplicate two times per
subarray. Raw signal intensities for each peptide spot are normalized to the average IgG control signal on an individual subarray. (C) Heat maps showing
the influence of neighboring PTMs on the indicated wild-type and mutant TTD-PHD interactions with arrayed H3(1–20) K9me3 (top), H3(1–20) K9me2
(middle) or H3(1–20) K9me1 (bottom) peptides.

UHRF1, but not UHRF2, selectively binds He5mC
As the chromatin binding requirements of UHRF1 rely on
both histone and DNA recognition (24), we next sought to
compare the DNA binding properties of these two proteins.
We again used FP binding assays to measure interactions
between full-length UHRF1 and UHRF2 with 12-bp DNA
oligonucleotides harboring a single, centrally-located CpG
that was either unmodified (UnDNA), hemi-methylated
(He5mC), or symmetrically methylated (Sy5mC). UHRF1
displayed a 9- to 32-fold increase (NaCl-dependent) in affinity for He5mC over UnDNA (Figure 3A, B left). However,

UHRF2 had substantially reduced selectivity, in comparison to UHRF1, for either He5mC or Sy5mC over UnDNA
(Figure 3A and B, right). We note a 2-fold affinity increase
for He5mC over UnDNA for UHRF2 (Figure 3B, right),
which may represent the error in fitting data without a clear
upper plateau.
We and others previously reported a reciprocal positive
allosteric relationship between the histone and DNA binding domains of UHRF1 (22–24). Consistent with our previous results, unlabeled H3(1–20) K9me3 peptides enhanced
the interaction of UHRF1 with both UnDNA and He5mC
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Figure 2. Multivalent histone engagement of UHRF proteins. Fluorescence polarization (FP) binding assays quantifying the interactions between wildtype (A) and mutant (B, C) TTD-PHD domains of UHRF1 or UHRF2 and the indicated FAM-labeled H3 peptides. Error bars represent s.e.m. from
technical triplicate measurements. n.m., not measurable.

(Figure 3B, left). As observed for UHRF1, UHRF2 also
maintains a positive allosteric relationship between histone
and DNA binding (Figure 3B, right).
Although the reported affinity preference was modest (∼
3-fold preference for Sy5hmC over UnDNA), UHRF2 was
previously reported to read 5hmC (33). We therefore sought
to compare binding of UHRF1 and UHRF2 to 12-bp oligos modified with hemi-hydroxymethylated (He5hmC) and
symmetrically hydroxymethylated (Sy5hmC) DNA (Figure
3C). Neither UHRF1, nor UHRF2, displayed increased
affinity for DNA based on the hydroxymethyl state of a
single CpG dinucleotide in our binding assay. Collectively,
these results revealed that while UHRF1 and UHRF2 DNA
binding activities were enhanced by histone engagement,

UHRF2 lacked an increased affinity for He5mC in this sequence context. Furthermore, neither UHRF1 nor UHRF2
had a preference for He5hmC or Sy5hmC in this DNA sequence context.
UHRF1 and UHRF2 ubiquitin ligase activities are allosterically activated by hemi-modified DNA
As we previously showed that UHRF1 ubiquitin ligase
activity toward H3 substrates was stimulated by He5mC
oligonucleotides (24), we hypothesized that a lack of selective binding to He5mC, relative to UHRF1, would compromise the ubiquitin ligase activity of UHRF2. To test
this hypothesis, we next performed comparative in vitro
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Figure 3. DNA binding analysis of full length UHRF1 and UHRF2 reveals divergence in He5mC reader activity. (A–C) FP binding assays quantifying
the interactions between full-length UHRF1 (left) or UHRF2 (right) and the indicated FAM-labeled DNA oligonucleotides. For (B), FP measurements
were made in the presence of a saturating concentration (13 M) of H3(1–20) K9me3. Error bars represent S.E.M. from technical triplicate measurements
(A, B: 150 mM NaCl; C: 100 mM NaCl).

ubiquitination reactions for UHRF1 and UHRF2 with
H3(1–32) K9me2 peptide substrates in the absence or presence
of saturating concentrations of modified DNA oligonucleotides (Figure 4A). Consistent with previous results,
UHRF1 activity toward histone substrates and toward itself (auto-ubiquitination) was stimulated by He5mC. Surprisingly, UHRF2 enzymatic activity was also stimulated by
He5mC, despite having substantially reduced selectivity for

this mark over UnDNA, relative to UHRF1 (Figure 3A,
B, and Figure 4A). In addition, He5hmC, but not Sy5hmC
stimulated the enzymatic activity of UHRF2, and to a lesser
extent UHRF1.
We next performed a time-course analysis of hemimodified DNA activation of UHRF1 and UHRF2 ligase
activities. UHRF1 and UHRF2 were indistinguishable in
their ability to ubiquitinate themselves and H3(1–32) K9me2
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Figure 4. UHRF1 and UHRF2 E3 ligase activities are allosterically activated by hemi-modified DNA toward histone substrates. (A) In vitro ubiquitination of H3(1–32) K9me2 by UHRF1 (left) or UHRF2 (right) in the absence or presence of a saturating concentration (6.25 M) of the indicated DNA
oligonucleotides. Time course in vitro ubiquitination of H3(1–32) K9me2 by UHRF1 (left) or UHRF2 (right) in the presence of a saturating concentration
(6.25 M) of He5mC (B) or He5hmC (C).

peptide substrates in the presence of He5mC (Figure 4B).
However, UHRF2 (but not UHRF1) enzymatic activity toward H3(1–32) K9me2 peptide substrates was rapidly stimulated in the presence of He5hmC despite a lack of preference
toward this mark for either protein (Figure 4C and Figure
3C). We note that the N-terminal MBP-tag slows the kinetics of the UHRF2 ubiquitination reaction (Supplementary Figure S4A), and we took advantage of this to capture
the dynamics of He5hmC-stimulated UHRF2 ubiquitination (Supplementary Figure S4B, left). Introducing a lossof-function mutation in the UHRF2 SRA (Supplementary
Figure S3) disrupted He5hmC-dependent ubiquitin activity
toward H3(1–32) K9me2 peptide substrates (Supplementary
Figure S4B). Collectively, these results demonstrated that
UHRF1 and UHRF2 ubiquitin ligase activity is stimulated
by He5mC, and that UHRF2 (but not UHRF1) activity is

robustly stimulated by He5hmC and its interaction with the
SRA domain. This is, to our knowledge, the first example
of an E3 ubiquitin ligase allosterically regulated by DNA
hydroxymethylation. Importantly, these results suggest that
hemi-modified DNAs allosterically activate E3 ligase activity towards peptide substrates through a conformational
change in UHRF proteins that is not discernable through
FP binding measures.
UHRF2 ubiquitin ligase activity towards histones is restricted
by chromatin
To evaluate how mutations in UHRF2 chromatin reading domains (TTD*, PHD*, and SRA*: G477D, Supplementary Figure S3) affected chromatin binding in cells,
we performed chromatin association assays with FLAGtagged UHRF2 (Figure 5A). In a behavior shared with

Downloaded from https://academic.oup.com/nar/article-abstract/46/9/4405/4913573 by University of the Pacific user on 20 November 2018

DNA:

None

TAMRA-ub

Nucleic Acids Research, 2018, Vol. 46, No. 9 4413

SRA*

PHD*

TTD*

WT

mock

Soluble

SRA*

TTD*

PHD*

mock

SRA*

Chromatin

PHD*

TTD*

WT

mock

Total

WT

A

100 kD

FLAG (UHRF2)
β-tubulin

50 kD

UHRF2

UHRF1

B

UHRF1

UHRF2
auto-ub UHRF

75 kD

tri-ub HeLa mononucs
di-ub HeLa mononucs
mono-ub HeLa mononucs

25 kD
15 kD
time:
(min)

mono-ub H3(1-32)K9me2
1

5

10

1

5

H3(1-32)K9me2 + He5mC

10

1

5

10

1

5

10

HeLa mononucleosomes

Figure 5. UHRF1 and UHRF2 diverge in their ability to ubiquitinate nucleosomal histones. (A) Chromatin association assays for FLAG-tagged UHRF2
(WT) or the indicated mutants from asynchronously growing HeLa cells. Mock treatment represents an empty vector control. (B) Comparative in vitro
ubiquitination of H3(1–32) K9me2 (left) and HeLa mononucleosomes (right) by UHRF1 and UHRF2. Moles of H3 are equivalent in these reactions.

UHRF1 (24), mutation of either histone- or DNA-binding
domains reduced the amount of chromatin-bound UHRF2
in HeLa extracts. We next sought to compare E3 ligase activities of UHRF1 and UHRF2 on physiologic chromatin
substrates using purified HeLa mononucleosome preparations. Surprisingly, UHRF2 was unable to ubiquitinate
histones in the context of nucleosomes (Figure 5B, Supplementary Figure S5B). Auto-ubiquitination of UHRF2
in these assays confirmed the enzyme was active. We also
performed a comparative ubiquitination reaction between
UHRF1 and UHRF2 with both peptides and mononucleosomes where H3(1–32) K9me2 was in two-fold molar excess over mononucleosomes to maintain equivalent moles
of H3 (Figure 5B). Consistent with our initial findings (Figure 4B), UHRF1 and UHRF2 ubiquitin ligase activities toward H3(1–32) K9me2 peptide substrates were similar (Figure
5B, left), but the activity difference toward histones was revealed when queried on nucleosomal substrates (Figure 5B,
right). A possible explanation for the differences between
UHRF1 and UHRF2 ligase activity in these assays was that
UHRF2 binding to nucleosomes was weaker than UHRF1.
However, pulldown assays would suggest the contrary, as
more UHRF2 (TTD-PHD and full-length) pulled down
with recombinant unmodified and H3K9me3-containing
mononucleosomes than UHRF1 (Supplementary Figure
S5C). Collectively, these findings show that while histone
and DNA binding is required to target UHRF2 to bulk
chromatin in cells, the assembly of UHRF2 on chromatin is
likely distinct from UHRF1, resulting in a geometry unfavorable for histone ubiquitination. Consistent with this hypothesis, we were unable to stimulate UHRF2 enzymatic

activity toward nucleosomal histone substrates by swapping the UHRF2 SRA with that of UHRF1 (Supplementary Figure S5B). Notably, a TTD-SRA swap was also not
active as a nucleosomal histone E3 ligase, suggesting regions outside the chromatin binding unit also contribute
to positioning UHRF1 in a conformation productive for
nucleosomal histone ubiquitination. Both chimeric proteins
retained auto-ubiquitination. As ubiquitination of H3K18
and H3K23 is required for the binding of DNMT1 to chromatin (13), our studies reveal a key biochemical difference
between UHRF1 and UHRF2, at the level of nucleosomal
histone ubiquitination, that restricts the ability of UHRF2
to functionally complement for UHRF1 as a regulator of
DNA methylation maintenance.
DISCUSSION
Here we present a comprehensive biochemical comparison
between two highly conserved E3 ubiquitin ligases, UHRF1
and UHRF2, and we reveal similarities and differences in
chromatin recognition through histone and DNA binding,
as well E3 ligase activities (summarized in Supplementary
Table S4). This study sheds light on how multivalent chromatin engagement controls the enzymatic activity of UHRF
proteins. We demonstrate that on H3 peptides, UHRF1
and UHRF2 E3 ligase activities are indistinguishably activated by He5mC. However, UHRF2 E3 ligase activity is
robustly activated by He5hmC, while UHRF1 is not. This
is, to our knowledge, the first allosteric function identified
for 5hmC and suggests UHRF2 may play a role in the regulation and/or maintenance of this mark. Consistent with
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main of UHRF2 (SRA*: G477D) by introducing a negatively charged aspartic acid where the DNA backbone
contacts the SRA domain (Supplementary Figure S3).
The UHRF2 SRA* was informed by structural alignment
with the UHRF1 SRA, and generation of the homologous UHRF1 G448D mutant known to disrupt DNA binding (24,48). We found that in addition to histone binding, DNA binding was required for UHRF2 chromatin
association (Figure 5A). The co-requisites of histone and
DNA binding for chromatin association revealed the multivalent nature of UHRF2, a behavior shared with UHRF1
(20,21,24). To comparatively evaluate the DNA binding
properties of UHRF1 and UHRF2, we performed FP binding assays with modified DNA. UHRF1 demonstrated
increased affinity toward He5mC DNA over UnDNA,
whereas UHRF2 had minimal preference for methylated
DNA of any state (Figure 3). In a behavior that is shared
with UHRF1, the presence of H3K9me3 peptide increased
affinity for DNA as measured by FP (Figure 3B). Although
this positive allosteric mechanism is not structurally understood, we and others previously reported an interaction between the UHRF1 TTD-PHD and SRA-RING, and this
interaction was modulated by DNA binding (23,24). It is
important to note that this behavior was generally described
for DNA, regardless of the methylation status. Understanding the coordinated binding of histone and DNA, for both
UHRF1 and UHRF2, will require structural knowledge of
the intra-domain organization of these proteins.
Existing data supporting UHRF proteins as specific
readers of 5hmC is inconsistent (32,33,49). Crystal structures of the SRA domain of UHRF2 with He5mC and
He5hmC have been solved, despite lacking increased affinity for either DNA probe over UnDNA, as measured by FP
(33). To clarify whether UHRF1 or UHRF2 were readers
of 5hmC, we measured binding to He5hmC and Sy5hmC
DNA probes (Figure 3C). Neither UHRF1 nor UHRF2
showed increased affinity for 5hmC in either context by FP.
Possible explanations for differences in our binding measures compared to others could be the composition of the
DNA probe and the salt concentration used. Our probe is
12-bp in length with a single, centrally located CpG. Other
studies have used longer probes with multiple 5hmC CpGs
to enrich for UHRF2 (32). Measuring interactions with
longer DNA probes with multiple 5hmC sites may reveal
differences in stoichiometry rather than differences in affinity. Previous studies demonstrated salt concentration as a
critical regulator of DNA binding constants (23,24), where
lower salt resulted in tighter binding to DNA for UHRF1.
We used both 100 mM and 150 mM NaCl for binding assays in this study, which must be considered when comparing our results to others. It is also possible that structural
studies and binding assays with isolated domains do not accurately reflect the full-length protein behavior, as has been
shown here for histone binding (Figure 2A and Supplementary Figure S5A), as well as by others for DNA binding
(23,24).
Comparative ubiquitination assays for UHRF1 and
UHRF2 were surprising in many ways. The first surprise
was that both He5mC and He5hmC DNA probes activated
the E3 ligase activity of UHRF1 toward H3K9me2 peptides
(Figure 4A), although to a lesser degree for He5hmC. We
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this hypothesis, the enzymatic activity of TET2 was shown
to be stimulated by UHRF2, and knockdown of UHRF2
resulted in accumulation of 5mC (30,32).
On nucleosome substrates, UHRF1 actively ubiquitinates histones, while UHRF2 does not. Our data show that
the enzymatic differences between UHRF1 and UHRF2
are not due to histone substrate binding affinity differences
(Supplementary Figure S5A, C). Rather, we suggest that
when UHRF1 and UHRF2 engage histones and DNA in
the context of a nucleosome, they adopt unique supertertiary structures (46). UHRF2 is constrained in a conformation that is incompatible with enzymatic activity toward histones, while UHRF1 is in a productive conformation. As
UHRF2 is unable to deposit H3 ubiquitination, a proposed
recruitment mechanism for DNMT1, UHRF2 is uncoupled
from the maintenance of DNA methylation and unable to
functionally compensate for UHRF1.
Our histone peptide microarray experiments revealed
many subtle differences between UHRF1 and UHRF2 histone recognition, suggesting these H3 binding units may
not be completely conserved in their mode of recognition.
For peptides containing H3K9me2/me3, H3R2me2a and
H3K4ac was tolerated by UHRF2, but not by UHRF1,
while H3K4me3 was tolerated by UHRF1 but not for
UHRF2 (Figure 1C). The differing influence of N-terminal
modifications on UHRF1 and UHRF2 histone recognition suggests differences in the PHD domain and its interaction with the N-terminus of H3 (Supplementary Figure S2A, B). Indeed, in-cell validation of UHRF2 histone
binding revealed that less UHRF2 was bound to chromatin with a loss-of-function mutation in the TTD than the
PHD (Figure 5A). Interestingly, after filtering the microarray results for singly modified H3(1–20) peptides, we found
that UHRF1 top hits included H3R8me1, H3R8me2s,
H3K9me2, H3K18me3, and H3K14me3 (Supplementary
Figure S2). The top hits for UHRF1 have not all been reported, and may represent new marks read by UHRF1.
In contrast, UHRF2 top hits were clearly H3K9me3 and
H3K9me2. Although we did not measure tighter binding
for UHRF2 with H3 peptides than UHRF1 by FP (Figure 2A), this may be due to differences in the experimental
setup of each assay. For FP assays, H3 tail peptides are in
solution and free of any steric hindrance that may be provided by the nucleosome core particle or DNA. The microarray presents peptides immobilized on glass and may
be more sterically representative of a histone tail protruding
from the nucleosome core particle. Collectively, these data
support that UHRF2 interaction with histones is more reliant on the TTD domain than the PHD domain. Comparative structural analysis of UHRF1 and UHRF2 TTD-PHD
is likely to reveal subtle differences in the organization of
these linked histone binding modules (there is no structure
of UHRF2 TTD-PHD bound to H3).
UHRF1 and UHRF2 are the only mammalian proteins
with an SRA domain. SRA domains have been extensively characterized as DNA binding domains in plants,
and structural studies of SRA domains and various DNA
probes consistently revealed a base flipped out of the DNA
helix into a hydrophobic pocket of the SRA (14–16,47).
To compare the DNA binding properties of UHRF1 and
UHRF2, we first generated a mutation in the SRA do-
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